Benzinga | Mar 11, 2021 07:16AM EST

BioXcel Therapeutics Q4 EPS $(0.87) Beats $(0.96) Estimate

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(0.96) by 9.37 percent. This is a 93.33 percent decrease over losses of $(0.45) per share from the same period last year.